Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 81.
51. lappuse
... monohydrate Sodium phosphate , dibasic anhydrous rea- gent ' ( 3 ) Antidiarrheal drug products . Aluminum hydroxide Atropine sulfate Calcium carbonate Carboxymethylcellulose sodium Glycine Homatropine methylbromide Hyoscyamine sulfate ...
... monohydrate Sodium phosphate , dibasic anhydrous rea- gent ' ( 3 ) Antidiarrheal drug products . Aluminum hydroxide Atropine sulfate Calcium carbonate Carboxymethylcellulose sodium Glycine Homatropine methylbromide Hyoscyamine sulfate ...
313. lappuse
... monohydrate . Imipenem monohydrate is an antibiotic substance having the chemical structure de- scribed by the following name : [ 5R- [ 5α , 6a , ( R * ) ] ] - 6- ( 1 - hydroxyethyl ) -3 - [ [ 2- [ ( iminomethyl ) amino ] ethyl ] thio ] ...
... monohydrate . Imipenem monohydrate is an antibiotic substance having the chemical structure de- scribed by the following name : [ 5R- [ 5α , 6a , ( R * ) ] ] - 6- ( 1 - hydroxyethyl ) -3 - [ [ 2- [ ( iminomethyl ) amino ] ethyl ] thio ] ...
329. lappuse
... monohydrate means the imipenem activity ( potency ) contained in 1.085 micrograms of the imipenem master standard . ( 90 ) Cefotetan . The term " microgram ” applied to cefotetan means the cefotetan activity ( potency ) contained in ...
... monohydrate means the imipenem activity ( potency ) contained in 1.085 micrograms of the imipenem master standard . ( 90 ) Cefotetan . The term " microgram ” applied to cefotetan means the cefotetan activity ( potency ) contained in ...
360. lappuse
... monohydrate 4 3.0 1.0 Minocycline hydrochloride 4 5.0 Plicamycin 3 0.050 1.0 Mitomycin 4 0.050 1.0 Oxytetracycline 5 ... monohydrate 5 Dilu- ent 1 of test solution test so- to be in- lution 2 jected 3 4 5.0 .6 3 5.0 .6 4 1.0 1.0 1 ...
... monohydrate 4 3.0 1.0 Minocycline hydrochloride 4 5.0 Plicamycin 3 0.050 1.0 Mitomycin 4 0.050 1.0 Oxytetracycline 5 ... monohydrate 5 Dilu- ent 1 of test solution test so- to be in- lution 2 jected 3 4 5.0 .6 3 5.0 .6 4 1.0 1.0 1 ...
362. lappuse
... monohydrate : 3.97 gm . phosphate Disodium hydrogen phosphate anhydrous : 3.55 gm . Distilled water , q.s .: 1,000.0 mL . [ 39 FR 18944 , May 30 , 1974 , as amended at 40 FR 52004 , Nov. 7 , 1975 ; 45 FR 75194 , Nov. 14 , 1980 ; 47 FR ...
... monohydrate : 3.97 gm . phosphate Disodium hydrogen phosphate anhydrous : 3.55 gm . Distilled water , q.s .: 1,000.0 mL . [ 39 FR 18944 , May 30 , 1974 , as amended at 40 FR 52004 , Nov. 7 , 1975 ; 45 FR 75194 , Nov. 14 , 1980 ; 47 FR ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning